USA Market Access: Determining the commercial viability of healthcare innovations
Van derden25/10/22
Brightlands Medical Device Masterclass
USA Market Access: Determining the commercial viability of healthcare innovations
The USA market is the largest market in the world for medical innovation and determining early an innovation’s commercial viability potential is a key gating item for achieving success in this market. In this Masterclass, you will gain a better understanding of the unique complexities of the USA market, the motivations of the numerous stakeholders involved in the decision-making process; and how to effectively assess, plan and understand the full potential of an innovation’s commercial viability in the USA.
This Masterclass is organized by Brightlands and RQR Capital especially for University startups.
Masterclass Agenda
- Reimbursement and Health Economics: Coding, Coverage and Payment
The US is a consumer driven healthcare market with significant patient costs, which is influenced by profit driven mentality of insurance providers, hospitals and clinicians. Profit and loss are as much of a concern as patient care.
- Market Access; Penetration, Utilization, Adoption
Understanding the point of care dynamics is a key component to success. In the USA, this is a long process with significant challenges. Learning who the stakeholders are and gaining access is dependent on understanding the motivations of all the key decision makers.
- Strategic Pricing: Effectively maximize impact and profitability.
What is the value of the problem you are solving, and what will they pay for it? Analyzing workflow, stakeholder benefits and motivations while understanding how an innovation creates value throughout the entire patient journey and continuum of care.
Sign up!
Sign up if you are a startup or planning one.
Program
4:00pm – 4:30pm Registration
4:30pm – 6:00pm Masterclass
6:00pm – 7:00pm Reception and Networking
Speakers
James Sargent
James is the Founder and Managing Partner. He is an experienced global healthcare executive and trusted advisor to an extensive network of entrepreneurs, government leaders, and investors across the globe. Previously, Jim served in numerous commercial and general management leadership roles within Boston Scientific, including Asia Pacific.
Michael Phalen
Michael is the retired EVP and Group President of the MedSurg reporting segment for Boston Scientific, where he provided global strategic leadership to BSC’s Endoscopy, Urology and Neuromodulation businesses. Under Mike’s leadership, BSC successfully executed over $2 billion in M&A transactions and integrations. Mike has served on numerous industry boards.
Maria Stewart
Maria recently retired from Boston Scientific, where she led a global team of health economists and market access professionals delivering rigorous peer-reviewed evidence of reimbursement value and enhancing global market opportunities by securing optimal insurance coverage and payment for the company’s product portfolio.
More information & registration
Please go to the website.
